Cargando…
Immune checkpoint blockades in gynecological cancers: A review of clinical trials
Advanced and recurrent gynecological cancers are associated with a poor prognosis and there is still a lack of effective treatments. Immune checkpoint blockade (ICB) therapy is an important element of cancer‐targeted therapy and immunotherapy. The programed cell death protein 1 (PD‐1) and cytotoxic...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9564814/ https://www.ncbi.nlm.nih.gov/pubmed/35751489 http://dx.doi.org/10.1111/aogs.14412 |